Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CNT037
MIFTS: 35

Central Nervous System Germinoma

Categories: Cancer diseases, Endocrine diseases, Neuronal diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Central Nervous System Germinoma

About this section

MalaCards integrated aliases for Central Nervous System Germinoma:

Name: Central Nervous System Germinoma 12 53 15 73
Germinoma of the Central Nervous System 53 59
Intracranial Germinoma 53 73
Germinoma of Cns 12

Characteristics:

Orphanet epidemiological data:

59
germinoma of the central nervous system
Inheritance: Not applicable; Age of onset: Adolescent,Adult,Childhood;

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Neuronal diseases Endocrine diseases
See all MalaCards categories (disease lists)
Orphanet: 59  
Rare neurological diseases
Rare endocrine diseases


External Ids:

Disease Ontology 12 DOID:4438
NCIt 50 C7009
Orphanet 59 ORPHA91352
UMLS via Orphanet 74 C1333813
Sources

Summaries for Central Nervous System Germinoma

About this section
MalaCards based summary : Central Nervous System Germinoma, also known as germinoma of the central nervous system, is related to brain germinoma and diabetes insipidus. An important gene associated with Central Nervous System Germinoma is JMJD1C (Jumonji Domain Containing 1C), and among its related pathways/superpathways are Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways and G alpha (s) signalling events. The drugs Carboplatin and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and lung.

Sources

Related Diseases for Central Nervous System Germinoma

About this section

Diseases in the Central Nervous System Germinoma family:

Adult Central Nervous System Germinoma

Diseases related to Central Nervous System Germinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
# Related Disease Score Top Affiliating Genes
1 brain germinoma 32.6 AVP POU5F1
2 diabetes insipidus 30.2 AVP POMC
3 seminoma 30.0 ALPP POU5F1
4 pituitary hormone deficiency, combined, 2 29.6 AVP POMC
5 childhood central nervous system germinoma 12.5
6 adult central nervous system germinoma 12.4
7 malignant leydig cell tumor 10.1 POMC POU5F1
8 multiple sclerosis 10.0
9 endodermal sinus tumor 10.0
10 embryonal carcinoma 10.0
11 medulloblastoma 10.0
12 lennox-gastaut syndrome 10.0 ALPP POMC
13 germ cell cancer 10.0 ALPP POU5F1
14 malignant teratoma 9.9 AVP POU5F1
15 tuberculous epididymitis 9.9 AVP POMC
16 lung oat cell carcinoma 9.9 AVP POMC
17 bronchus cancer 9.9 AVP POMC
18 inappropriate adh syndrome 9.9 AVP POMC
19 olfactory nerve neoplasm 9.9 AVP POMC
20 secondary hypertrophic osteoarthropathy 9.9 AVP POMC
21 syndrome of inappropriate antidiuretic hormone 9.9 AVP POMC
22 cervix small cell carcinoma 9.9 AVP POMC
23 diabetes insipidus, neurohypophyseal 9.9 AVP POMC
24 epidermoid cysts 9.9
25 smith-lemli-opitz syndrome 9.9
26 opitz gbbb syndrome, type i 9.9
27 hypogonadotropic hypogonadism 9.9
28 cauda equina syndrome 9.9
29 cornelia de lange syndrome 9.9
30 glioblastoma multiforme 9.9
31 teratoma 9.9
32 choriocarcinoma 9.9
33 polyradiculopathy 9.9
34 embryonal testis carcinoma 9.9
35 in situ carcinoma 9.9
36 hypopituitarism 9.9
37 glioblastoma 9.9
38 lymphocytic hypophysitis 9.9
39 tremor 9.9
40 growing teratoma syndrome 9.9
41 cranial nerve malignant neoplasm 9.9 AVP POMC
42 premenstrual tension 9.9 AVP POMC
43 chromophobe adenoma 9.9 AVP POMC
44 pituitary gland disease 9.9 AVP POMC
45 pancreas disease 9.8 AVP POMC
46 central nervous system germ cell tumor 9.8 AVP POMC POU5F1
47 urinary system disease 9.8 AVP POMC
48 small cell cancer of the lung 9.7 AVP POMC

Graphical network of the top 20 diseases related to Central Nervous System Germinoma:



Diseases related to Central Nervous System Germinoma
Sources

Symptoms & Phenotypes for Central Nervous System Germinoma

About this section
Sources

Drugs & Therapeutics for Central Nervous System Germinoma

About this section

Drugs for Central Nervous System Germinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 95)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 6055-19-2, 50-18-0 2907
3
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
4
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
5
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
6
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 1 1177-87-3
7
Ondansetron Approved Phase 3 99614-02-5 4595
8
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
9
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1 50-02-2 5743
10 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
11 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
12 Immunologic Factors Phase 3,Phase 2,Phase 1
13 Alkylating Agents Phase 3,Phase 2,Phase 1
14 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
15 Etoposide phosphate Phase 3,Phase 2,Phase 1
16 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
17 Antirheumatic Agents Phase 3,Phase 2,Phase 1
18 Adjuvants, Immunologic Phase 3,Phase 1
19 Gastrointestinal Agents Phase 3,Phase 1
20 Antiemetics Phase 3,Phase 1
21 Autonomic Agents Phase 3,Phase 1
22 BB 1101 Phase 3,Phase 1
23 Peripheral Nervous System Agents Phase 3,Phase 1
24 Emetics Phase 3
25
Bleomycin Approved, Investigational Phase 2 11056-06-7 5360373
26
Thiotepa Approved, Investigational Phase 2,Phase 1 52-24-4 5453
27
Mechlorethamine Approved, Investigational Phase 2,Phase 1 51-75-2 4033
28
Ifosfamide Approved Phase 2,Phase 1 3778-73-2 3690
29
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
30 Antibiotics, Antitubercular Phase 2
31 Anti-Bacterial Agents Phase 2,Phase 1
32
Isophosphamide mustard Phase 2,Phase 1 0
33 Antimitotic Agents Phase 2,Phase 1
34 Liver Extracts Phase 1, Phase 2
35 Protein Kinase Inhibitors Phase 1, Phase 2
36 Keratolytic Agents Phase 2
37 Podophyllotoxin Phase 2 518-28-5
38 Dermatologic Agents Phase 2
39
Dacarbazine Approved, Investigational Phase 1 4342-03-4 5351166
40
Temozolomide Approved, Investigational Phase 1 85622-93-1 5394
41
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
42
Bortezomib Approved, Investigational Phase 1 179324-69-7 387447 93860
43
leucovorin Approved Phase 1 58-05-9 6006 143
44
Fluorouracil Approved Phase 1 51-21-8 3385
45
Oxaliplatin Approved, Investigational Phase 1 61825-94-3 43805 6857599 5310940 9887054
46
Levoleucovorin Approved, Investigational Phase 1 68538-85-2
47
Sunitinib Approved, Investigational Phase 1 557795-19-4, 341031-54-7 5329102
48
Vincristine Approved, Investigational Phase 1 57-22-7, 2068-78-2 5978
49
Mannitol Approved, Investigational Phase 1 69-65-8 453 6251
50
Acetylcysteine Approved, Investigational Phase 1 616-91-1 12035

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor Completed NCT00085098 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
2 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
3 Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma Unknown status NCT02782754 Phase 2 Carboplatin;Etoposide;Cyclophosphamide;Bleomycin
4 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Completed NCT00047320 Phase 2 carboplatin;etoposide;ifosfamide;thiotepa
5 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors Completed NCT00002472 Phase 2 cisplatin;etoposide
6 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
7 Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Suspended NCT01602666 Phase 2 Carboplatin;Etoposide;Ifosfamide
8 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
9 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
10 Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00929903 Phase 1 pazopanib hydrochloride
11 Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors Completed NCT00281944 Phase 1 oxaliplatin;fluorouracil;leucovorin calcium
12 Sunitinib in Treating Young Patients With Refractory Solid Tumors Completed NCT00387920 Phase 1 sunitinib malate
13 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Completed NCT01273090 Phase 1 imetelstat sodium
14 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
15 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Completed NCT00003141 Phase 1 carboplatin;cisplatin;cyclophosphamide;etoposide;thiotepa;vincristine sulfate
16 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;dexamethasone
17 Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors Terminated NCT00238173 Phase 1 acetylcysteine;carboplatin;cyclophosphamide;etoposide phosphate;mannitol;sodium thiosulfate
18 Collecting and Storing Tissue From Young Patients With Cancer Completed NCT00898755
19 Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors Withdrawn NCT00897858

Search NIH Clinical Center for Central Nervous System Germinoma

Sources

Genetic Tests for Central Nervous System Germinoma

About this section
Sources

Anatomical Context for Central Nervous System Germinoma

About this section

MalaCards organs/tissues related to Central Nervous System Germinoma:

41
Brain, Liver, Lung, Pituitary, Pancreas, Cervix, Testis
Sources

Publications for Central Nervous System Germinoma

About this section

Articles related to Central Nervous System Germinoma:

(show all 16)
# Title Authors Year
1
Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation. ( 26744133 )
2016
2
Improvement of Long-term Results with Neoadjuvant Chemotherapy andA Radiotherapy for Central Nervous System Germinoma. ( 26115804 )
2015
3
Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma. ( 23754592 )
2013
4
An unusual case of primary central nervous system germinoma with meningeal dissemination. ( 22936081 )
2012
5
Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation. ( 21495164 )
2011
6
Outcome of central nervous system germinoma treatment by chemoradiation. ( 21516012 )
2011
7
Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. ( 20045266 )
2010
8
Regression of primary central nervous system germinoma after dexamethasone administration: a case report. ( 20367268 )
2010
9
Management of central nervous system germinoma: proposal for a modern strategy. ( 19329866 )
2009
10
Diffusion-weighted imaging characteristics of primary central nervous system germinoma with histopathologic correlation: a retrospective study. ( 19643635 )
2009
11
Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. ( 19326417 )
2009
12
OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. ( 15725806 )
2005
13
Patterns of failure after induction chemotherapy followed by consolidative radiation therapy for children with central nervous system germinoma. ( 14595717 )
2003
14
Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. ( 9420074 )
1998
15
Radiation therapy for histologically confirmed primary central nervous system germinoma. ( 9276355 )
1997
16
Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy: report of 10 patients. ( 6256407 )
1981
Sources

Variations for Central Nervous System Germinoma

About this section
Sources

Expression for Central Nervous System Germinoma

About this section
Search GEO for disease gene expression data for Central Nervous System Germinoma.
Sources

Pathways for Central Nervous System Germinoma

About this section

Pathways related to Central Nervous System Germinoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 1
11.37 AVP POU5F1
2
G alpha (s) signalling events 66
11.12 AVP POMC
3
Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers 65
10.75 ALPP POU5F1
Sources

GO Terms for Central Nervous System Germinoma

About this section

Cellular components related to Central Nervous System Germinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 secretory granule GO:0030141 8.62 AVP POMC

Biological processes related to Central Nervous System Germinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 generation of precursor metabolites and energy GO:0006091 8.62 AVP POMC

Molecular functions related to Central Nervous System Germinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.96 AVP POMC
2 transcription regulatory region sequence-specific DNA binding GO:0000976 8.62 JMJD1C POU5F1
Sources

Sources for Central Nervous System Germinoma

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....